New Series: SOHO 'State of the Art Updates and Next Questions'

被引：0
|
作者：
Kantarjian, Hagop [1 ,2 ]
Talpaz, Moshe [1 ,3 ,4 ,5 ]
机构：
[1] Soc Hematol Oncol, The Woodlands, TX 77393 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Michigan, Sch Med, Leukemia Res, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Translat Res, Ann Arbor, MI USA
[5] Univ Michigan, Sch Med, Hematol Oncol, Ann Arbor, MI USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 08期
关键词：
D O I：
10.1016/j.clml.2017.06.036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 463
页数：1
相关论文
共 50 条
  • [31] SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection
    Mehta, Rohtesh S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (12): : 821 - 826
  • [32] SOHO State of the Art Updates and Next Questions: Treatment of Older, Vulnerable Adults with Multiple Myeloma
    Grant, Shakira J.
    Joshi, Girija
    Lipe, Brea
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : 279 - 286
  • [33] SOHO State of the Art Updates and Next Questions-WHO Classification of Acute Myeloid Leukemia
    Loghavi, Sanam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : 752 - 758
  • [34] SOHO State of the Art Updates and Next Questions: Understanding and Overcoming Venetoclax Resistance in Hematologic Malignancies
    Forsberg, Mark
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (01): : 1 - 14
  • [35] SOHO State of the Art Updates and Next Questions: Will CAR-T Replace ASCT in NDMM
    Jurgens, Eric
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (05): : 277 - 284
  • [36] SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management
    Gargiulo, Ernesto
    Ribeiro, Eduardo Flavio Oliveira
    Niemann, Carsten U.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (05): : 322 - 332
  • [37] SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALL
    Aldoss, Ibrahim
    Pourhassan, Hoda
    Douer, Dan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (11): : 787 - 794
  • [38] SOHO State of the Art Updates and Next Questions | Early Intervention in Myelofibrosis: Where Are We and Does It Matter?
    Yacoub, Abdulraheem
    Twardowski, Nicole
    Britt, Alec
    Shraim, Nour
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (08): : 506 - 511
  • [39] SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas
    Bhansali, Rahul S.
    Barta, Stefan K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (09): : 642 - 650
  • [40] SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It
    Patel, Anand A.
    Odenike, Olatoyosi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (05): : 303 - 309
12345